Welcome to our dedicated page for Dxc Technology SEC filings (Ticker: DXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for DXC Technology Company (NYSE: DXC), a Nevada-incorporated global information technology services provider and enterprise technology and innovation partner. Through these filings, investors and analysts can review how DXC reports on its operations, capital structure, governance, and material events.
DXC’s SEC submissions include Form 8-K current reports describing events such as changes to segment reporting, leadership changes, annual meeting voting results, senior notes offerings, and redemptions of existing debt. For example, DXC has filed 8-Ks detailing the pricing and issuance of 4.250% Senior Notes due 2030 through a wholly owned subsidiary, the planned full redemption and delisting of 1.750% Senior Notes due 2026, and partial redemption of 1.800% Senior Notes due 2026, as well as quarterly earnings releases.
Filings also include Form 25 notifications, such as the removal from listing and/or registration of the 1.750% Notes due 2026 on the New York Stock Exchange. Together with periodic reports like Forms 10-K and 10-Q (when available), these documents outline DXC’s segment structure, risk factors, financing arrangements, and other disclosures relevant to its role in managed infrastructure services, application modernization, insurance services, and industry-specific software solutions.
On Stock Titan, DXC’s SEC filings are updated in near real time from EDGAR and paired with AI-powered summaries to help readers quickly understand the purpose and implications of each document. Long annual reports (Form 10-K) and quarterly reports (Form 10-Q) can be distilled into key themes, while current reports (Form 8-K) are summarized to highlight the nature of each material event. Users can also review filings related to DXC’s debt instruments and other securities, and use the AI explanations to navigate complex indenture terms, covenant descriptions, and capital structure changes more efficiently.
DXC Technology (Form 144): This notice reports a proposed sale of 2,500 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $36,287.53 and an approximate sale date of 09/11/2025 on the NYSE. The shares were acquired on 05/23/2024 via restricted stock vesting as compensation. The filing also discloses a prior sale of 2,500 shares on 06/11/2025 generating gross proceeds of $39,836.03. The filing omits the issuer name and filer CIK/CCC details in the provided text.
Venkataraman Ramanathan, identified as an officer (EVP, CES) and director of DXC Technology Co (DXC), received an award of 86,780 restricted stock units (RSUs) reported as an acquisition on 08/15/2025. Each RSU converts to one share of common stock upon vesting, and the award will vest in three equal annual installments on the first, second and third anniversaries of the grant date. The form reports the amount includes unvested RSUs and shows 86,780 shares beneficially owned following the transaction. The transaction is recorded with a price of $0 and the Form 4 was signed by an attorney-in-fact, Matt Fawcett, on 08/19/2025.
Anthony Gonzalez, a director of DXC Technology Co (DXC), reported multiple sales of the issuer's common stock on 08/13/2025. The Form 4 shows four separate disposition transactions totaling 12,300 shares sold at prices ranging from $13.78 to $13.79. The filing notes that the reported beneficial ownership amounts include unvested restricted stock units. After the reported sales, Mr. Gonzalez's beneficial ownership in DXC is shown as 34,300 shares.
The filing is a Form 144 notice reporting a proposed sale of 12,300 common shares through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $169,519.84. The shares were acquired on 07/22/2025 via restricted stock vesting from the issuer and were paid as compensation. No securities were reported sold by the person in the past three months. The filing lists an approximate sale date of 08/13/2025.
DXC Technology (DXC) – Form 4 insider filing: Director David L. Herzog reported the grant of 25,700 restricted stock units (RSUs) on 08 Aug 2025. Each RSU converts to one DXC common share at no cost to the director.
• Vesting: earliest of one year after grant (08 Aug 2026) or the 2026 annual shareholder meeting. Shares settle at vesting or on a deferred date selected by the director.
• Ownership after grant: 116,401 DXC shares, including unvested RSUs. All holdings are listed as direct ownership.
The filing reflects routine director compensation rather than an open-market purchase or sale; therefore it does not alter the public float or signal a viewpoint on valuation. However, the additional equity modestly aligns the director’s incentives with shareholders.
FAQ
What is the current stock price of Dxc Technology (DXC)?
What is the market cap of Dxc Technology (DXC)?
